देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
aripiprazole, Quantity: 20 mg
Alembic Pharmaceuticals Australia Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; crospovidone; hyprolose; maize starch; silicon dioxide
Oral
30 tablets
(S4) Prescription Only Medicine
ALEMBIC Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.
Visual Identification: White to off white, round shaped bevelled edge, uncoated tablets debossed with L254 on one side and plain on other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2020-09-23